Screening, expression, and functional validation of camelid-derived nanobodies targeting RSPO2.
- DOI
- 10.1016/j.vetimm.2025.110922
- Published
- 2025 May
- Container
- Veterinary immunology and immunopathology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vetimm.2025.110922,
title = {Screening, expression, and functional validation of camelid-derived nanobodies targeting RSPO2.},
author = {Guo S and Shuaiying Z and Yingying K and Tang J and Xu J and Dai Y and Geng Y},
year = {2025},
journal = {Veterinary immunology and immunopathology},
doi = {10.1016/j.vetimm.2025.110922},
url = {https://doi.org/10.1016/j.vetimm.2025.110922}
}RIS
TY - JOUR TI - Screening, expression, and functional validation of camelid-derived nanobodies targeting RSPO2. AU - Guo S AU - Shuaiying Z AU - Yingying K AU - Tang J AU - Xu J AU - Dai Y AU - Geng Y PY - 2025 JO - Veterinary immunology and immunopathology DO - 10.1016/j.vetimm.2025.110922 UR - https://doi.org/10.1016/j.vetimm.2025.110922 ER -
APA
S, G., Z, S., K, Y., J, T., J, X., Y, D., & Y, G. (2025). Screening, expression, and functional validation of camelid-derived nanobodies targeting RSPO2.. Veterinary immunology and immunopathology. https://doi.org/10.1016/j.vetimm.2025.110922
Source records
- pubmed · retrieved 2026-09-26T21:23:17.392Z